These data indicate that pDCs are not essential in IBD pathogenesis, but their targeting by PSA may prevent colitis development, most likely through their ability to stimulate CD4+ T cell production of IL-10 (24). The gene discussed is CD4; the disease is inflammatory bowel disease.